.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Genetic testing is increasingly relevant in drug-resistant epilepsy because treatment response can differ by underlying cause. This 2024 retrospective cohort study compared ketogenic diet therapy in patients with drug-resistant epilepsy with and without identified genetic causes. The cohort included children with a range of genetic epilepsies and developmental and epileptic encephalopathies. Seizure frequency fell in both groups after ketogenic diet therapy, but the reduction was greater among patients with identified genetic etiologies. The study also found that patients with non-developmental-epileptic-encephalopathy genetic conditions appeared to derive greater benefit than those with developmental epileptic encephalopathy. The authors therefore suggest that genetic information may help clinicians identify patients for whom dietary therapy should be introduced earlier. The findings should be interpreted cautiously because the study was retrospective, treatment adherence differed across participants, and there was no randomised comparison group. Still, the study fits an important IANCON theme: moving from syndrome-based treatment toward biologically informed epilepsy care. For HCPs, genetic testing is not simply diagnostic; it may increasingly help shape treatment selection, counselling and expectations when drug-resistant epilepsy is being managed.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Genetic testing is increasingly relevant in drug-resistant epilepsy because treatment response can differ by underlying cause. This 2024 retrospective cohort study compared ketogenic diet therapy in patients with drug-resistant epilepsy with and without identified genetic causes. The cohort included children with a range of genetic epilepsies and developmental and epileptic encephalopathies. Seizure frequency fell in both groups after ketogenic diet therapy, but the reduction was greater among patients with identified genetic etiologies. The study also found that patients with non-developmental-epileptic-encephalopathy genetic conditions appeared to derive greater benefit than those with developmental epileptic encephalopathy. The authors therefore suggest that genetic information may help clinicians identify patients for whom dietary therapy should be introduced earlier. The findings should be interpreted cautiously because the study was retrospective, treatment adherence differed across participants, and there was no randomised comparison group. Still, the study fits an important IANCON theme: moving from syndrome-based treatment toward biologically informed epilepsy care. For HCPs, genetic testing is not simply diagnostic; it may increasingly help shape treatment selection, counselling and expectations when drug-resistant epilepsy is being managed.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
3 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
5 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
